This September, Marc Davies, VP Biomedical Informatics will be presenting at the Artificial Intelligence in Drug Development Congress on how machine learning technologies are changing how new medicines are discovered and developed.
Join Mark Rackam at ON Helix event in Cambridge where he will be presenting "When the Rubber Hits the Road: A Case Study of AI applied to ALS Drug Discovery"
Join Nathan Brown, Head of Chemoinformatics at BenevolentAI at the 19th Annual Drug Discovery Summit and 6th Annual Discovery Chemistry and Drug Design Congress.
This is a timely event which will examine the unprecedented disruption and transformation of industries, business and the jobs market due to advancements in Artificial Intelligence and Virtual and Augmented Reality.
Join Jackie Hunter, CEO BenevolentBio along with AI in Healthcare leaders to discuss the latest innovation in healthcare
Join world class speakers and our VP Drug discovery to discuss the challenges and opportunities in the area of new technologies and novel targets to improve the success of drug discovery
This conference will bring together key opinion leaders and senior industry experts to discuss the latest developments in drug discovery strategies, included Mark Davies, VP Bioinformatics at BenevolentAI.
Meet Jackie Hunter, CEO BenevolentBio and more than 500 healthcare, pharmaceutical and technology influencers and leaders at the fifth annual WIRED Health event in London.
Join Mark Rackham, Drug discovery scientist at BenevolentAI for a panel discussion on Precision Medicine and Biomarker Discovery
In 2016, total expenditure on prescription drugs in the US was estimated at $450 billion. During this year, almost half of the US population took at least one prescription medicine every month. It is essential that we find ways to streamline this process, removing inefficencies and unnecessary costs, while bringing efficacious prescription drugs to the population as soon as possible. We believe that Artificial Intelligence offers the best solutions to solve these issues.
The 5th annual Advanced Pharma Analytics Europe Summit 2018 is dedicated to bringing together Data Science and Advanced Analytics leaders to address the biggest challenges and opportunities in this space.
Join Ian Churcher, VP of Drug Discovery at BenevolentBio as he discusses Targeted Protein Degradation, one of the most exciting and fast growing areas of drug discovery. Ian will give an introduction to the area and highlight how AI approaches can be used to accelerate progress.
Jackie Hunter, CEO BenevolentAI is presenting at JP Morgan Healthcare Conference on the future of Pharma.
Join Jackie Hunter, CEO BenevolentBio who will share her thoughts and her experience.
Join Mark Davies, VP Biomedical Informatics at BenevolentAI for a talk on "Disrupting Drug Discovery with AI"
Join Rabia T. Khan, Exploratory Scientist at BenevolentAI for a panel discussion on What makes a great researcher: tools and skills.
Join Patrick Keohane, CMO at BenevolentAI for a panel on Disruption from Afar: Embracing New Non-Pharma Technologies & Actors
Jackie Hunter, CEO BenevolentBio and Jerome Pesenti, CEO BenevolentTech will be joining Web Summit this year.
Patrick Keohane, Chied Medical Officer at BenevolentBio will be presenting at the BioData World Congress 2017
Jerome Pesenti, CEO at BenevolentTech will be joining Data Driven Event held at Bloomberg LP to discuss how BenevolentAI artificial intelligence can accelerate drug discovery
Big Data is the process of analysing high volume, high velocity data by advanced computational methods that produce actionable knowledge...
Amir Saffari, Director of Applied AI will be discussing Machine Learning for Drug Discovery - Join the event
Translating UK scientific excellence in global therapeutics strategies
Meet Jérôme Pesenti, CEO BenevolentTech at Viva Technology in Paris